Scotia Capital’s Oak Street Health, Inc. OSH Stock Holding History

Scotia Capital’s Portfolio OSH Stock Details OSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-38,518	Closed	-$2.09M	–	876
2021 Q1	$2.09M	Buy	38,518 +3,969	+11%	+$221K	0.02%	350
2020 Q4	$2.11M	Buy	+34,549	New	+$1.81M	0.02%	321

Other funds holding OSH

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Newlight Partners New York $3.9M AUM 96.05% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Scotia Capital's OSH Position: Q2 2021 in Review

Scotia Capital sold out of Oak Street Health, Inc. (OSH) in Q2 2021, closing a stake of 38,518 shares — an estimated $2.09M sold.

Scotia Capital first reported a position in OSH in Q4 2020 and held it in 2 quarters. The position peaked at $2.11M in Q4 2020. 226 funds tracked by Wall St. Rank hold OSH as of Q2 2021.

Scotia Capital reported no remaining Oak Street Health, Inc. position as of Q2 2021 after selling out during the quarter.
Scotia Capital sold 38,518 Oak Street Health, Inc. shares in Q2 2021, an estimated $2.09M.
Scotia Capital first reported a position in Oak Street Health, Inc. in Q4 2020 and held it in 2 quarters.
Scotia Capital's Oak Street Health, Inc. position peaked at $2.11M in Q4 2020.
226 funds tracked by Wall St. Rank held Oak Street Health, Inc. as of Q2 2021.

Based on Scotia Capital's 13F filing for Q2 2021, filed 12 Aug 2021.